NCT04439214 · Interventional trial
Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)
Overall registry status Completed
Phase 2
Conditions Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Plasma Cell Myeloma
Delaware Valley sites
- ECOG-ACRIN Cancer Research Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory